Brokerages Expect LHC Group, Inc. (NASDAQ:LHCG) to Post $1.32 Earnings Per Share

Equities analysts expect that LHC Group, Inc. (NASDAQ:LHCGGet Rating) will announce earnings of $1.32 per share for the current quarter, according to Zacks Investment Research. Twelve analysts have provided estimates for LHC Group’s earnings. The lowest EPS estimate is $1.26 and the highest is $1.41. LHC Group posted earnings of $1.62 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 18.5%. The firm is scheduled to announce its next earnings results on Monday, January 1st.

On average, analysts expect that LHC Group will report full-year earnings of $5.76 per share for the current financial year, with EPS estimates ranging from $5.54 to $5.89. For the next fiscal year, analysts forecast that the business will report earnings of $6.83 per share, with EPS estimates ranging from $6.17 to $7.75. Zacks’ EPS calculations are an average based on a survey of sell-side analysts that that provide coverage for LHC Group.

LHC Group (NASDAQ:LHCGGet Rating) last issued its earnings results on Wednesday, May 4th. The health services provider reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.04. The firm had revenue of $571.50 million for the quarter, compared to analysts’ expectations of $573.10 million. LHC Group had a net margin of 4.44% and a return on equity of 10.11%. The business’s revenue was up 8.9% on a year-over-year basis. During the same quarter last year, the business earned $1.39 earnings per share.

A number of equities analysts have weighed in on LHCG shares. Barclays boosted their target price on LHC Group from $154.00 to $170.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 12th. Deutsche Bank Aktiengesellschaft downgraded LHC Group from a “buy” rating to a “hold” rating and cut their price target for the company from $190.00 to $170.00 in a research note on Monday, April 25th. StockNews.com initiated coverage on LHC Group in a research note on Thursday, March 31st. They set a “hold” rating for the company. William Blair downgraded LHC Group from an “outperform” rating to a “market perform” rating in a research note on Tuesday, March 29th. Finally, Benchmark downgraded LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, March 30th. Thirteen investment analysts have rated the stock with a hold rating, According to MarketBeat.com, LHC Group presently has a consensus rating of “Hold” and an average target price of $164.20.

A number of hedge funds have recently bought and sold shares of LHCG. Walleye Capital LLC purchased a new stake in shares of LHC Group during the 1st quarter worth approximately $910,000. First National Bank of Omaha raised its holdings in shares of LHC Group by 27.7% during the 1st quarter. First National Bank of Omaha now owns 58,261 shares of the health services provider’s stock worth $9,823,000 after acquiring an additional 12,653 shares in the last quarter. Van Hulzen Asset Management LLC raised its holdings in shares of LHC Group by 15.2% during the 1st quarter. Van Hulzen Asset Management LLC now owns 3,120 shares of the health services provider’s stock worth $526,000 after acquiring an additional 412 shares in the last quarter. Gabelli Funds LLC purchased a new stake in shares of LHC Group during the 1st quarter worth approximately $1,905,000. Finally, GABELLI & Co INVESTMENT ADVISERS INC. purchased a new stake in shares of LHC Group during the 1st quarter worth approximately $1,425,000. Institutional investors and hedge funds own 89.65% of the company’s stock.

Shares of LHCG traded down $0.63 during trading hours on Wednesday, hitting $166.03. The company had a trading volume of 379,106 shares, compared to its average volume of 518,155. The firm has a fifty day moving average price of $165.68 and a 200-day moving average price of $142.75. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.41 and a current ratio of 1.41. The stock has a market capitalization of $5.15 billion, a price-to-earnings ratio of 51.56, a P/E/G ratio of 2.57 and a beta of 0.45. LHC Group has a 52-week low of $108.42 and a 52-week high of $223.63.

About LHC Group (Get Rating)

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI).

Recommended Stories

Get a free copy of the Zacks research report on LHC Group (LHCG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LHC Group (NASDAQ:LHCG)

Want More Great Investing Ideas?

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.